Jun 02, 08
|
| NEW STORY |
| 14:55 ET |
Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
|
|
Nov 21, 07
|
| 14:11 ET |
Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
|
|
May 16, 07
|
| 18:19 ET |
Alliance Pharmaceutical Corp. Clinical Study to Be Initiated in France
|
|
May 15, 07
|
| 15:00 ET |
Alliance Pharmaceutical Corp. Provides Company Update
|
|
May 14, 07
|
| 14:17 ET |
IMCOR Pharmaceutical Co. Announces Plans to Cease Public Reporting
|
|
Apr 02, 07
|
| 20:38 ET |
Alliance Pharmaceutical Corp. Provides Company Update
|
|
Mar 15, 07
|
| 19:45 ET |
Alliance Pharmaceutical Corp. Updates Clinical Development of Oxygent(TM) in China
|
|
Feb 06, 07
|
| 13:55 ET |
Alliance Pharmaceutical Corp. Completes the Manufacture of Oxygent (TM) for Clinical Trials
|
|
Dec 18, 06
|
| 09:00 ET |
Alliance Pharmaceutical Corp. Clinical Study Approved to Start in France
|
|
Nov 07, 06
|
| 16:42 ET |
Alliance Pharmaceutical Corp. Provides Clinical Study Update
|
|
Jul 31, 06
|
| 20:30 ET |
Alliance Pharmaceutical Corp. Provides Clinical Study Update
|
|
Apr 20, 06
|
| 17:00 ET |
Alliance Pharmaceutical Corp. Announces Amendment of Its Senior Convertible Promissory Notes and Provides Operational Update
|
|
Mar 23, 06
|
| 20:24 ET |
Alliance Pharmaceutical Corp. Reaches Agreement With Lender Committee Related to the Restructuring of Its Senior Convertible Promissory Notes
|
|
Oct 13, 05
|
| 08:00 ET |
Alliance Pharmaceutical Corp. Appoints Jack DeFranco to President and Chief Operating Officer
|
|
Sep 22, 05
|
| 20:01 ET |
IMCOR Pharmaceutical Co., Alliance Pharmaceutical Corp., Molecular Biosystems, Inc. and GE Healthcare Ltd., Inc. Enter Into Cross-Licensing Agreement for Ultrasound Contrast Patents
|
|
Sep 07, 05
|
| 20:01 ET |
Alliance Pharmaceutical Corp. Announces the Transfer of Assets of Its Subsidiary Astral, Inc. to a MultiCell Technologies, Inc. Subsidiary in Exchange for a Funding Commitment and Retention of Equity Ownership in the MultiCell Subsidiary
|
|
May 18, 05
|
| 08:02 ET |
Alliance Pharmaceutical Corp. Announces Its Intention to Pursue Proof of Concept Study Relating to the Use of Oxygent(TM) for Organ Protection During Major Surgery
|
|
May 16, 05
|
| 08:05 ET |
Alliance Pharmaceutical Corp. And Beijing Double-Crane Pharmaceutical Co., Ltd. Announce a Development, License and Supply Agreement for Oxygent(TM) in The People's Republic Of China
|
|
Apr 05, 05
|
| 19:51 ET |
Alliance Pharmaceutical Corp. and Beijing Double-Crane Pharmaceutical Co., Ltd. Announce a Memorandum of Understanding Concerning the Development, Licensing and Marketing of Oxygent(tm) in The People's Republic of China
|
|